Sign inJoin waitlistJoin the waitlist

Barbara Craft

Medical Director · University of Mississippi School of Medicine

Credentials: · · ·

History

University of Mississippi School of Medicine
Present
University of Mississippi School of Medicine
Present
University of Mississippi School of Medicine
Present

University of Texas M D Anderson Cancer Center
2008–2010
Hematology and Medical Oncology
University of Mississippi Medical Center
2005–2008
Internal Medicine
University of Mississippi Medical Center
2002–2004
University of Mississippi School of Medicine
1998–2002
University of Southern Mississippi, BS, Biology
1993–1997

Research

Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test
European Journal of Pharmacology · 1999 · 195 citations
Comparative analysis of innate immune system function in metastatic breast, colorectal, and prostate cancer patients with circulating tumor cells
Experimental and Molecular Pathology · 2014 · 45 citations
Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis
Experimental and Molecular Pathology · 2015 · 43 citations

Eswara Mundra
2 papers · 1 as a fellow
Gabriel Hortobagyi
2 papers
Louis Puneky
2 papers
Srinivasan Vijayakumar
2 papers
SM
Stacy Moulder
2 papers
Asal Rahimi
1 paper
CC
Carter Capra
1 paper
DK
Daniel Karp
1 paper
Divyang Mehta
1 paper
EB
Elizabeth Bui
1 paper · 1 as a resident
Germame Ajebo
1 paper
Hiba Ahmed
1 paper · 1 as a resident

Clinical trials

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2023–2033
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2023–2033
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2017–2027